Literature DB >> 31251106

Quantification and assessment of detection capability in imaging mass spectrometry using a revised mimetic tissue model.

Jeremy A Barry1, Mark Reid Groseclose1, Stephen Castellino1.   

Abstract

Aim: A revised method of preparing the mimetic tissue model for quantitative imaging mass spectrometry (IMS) is evaluated. Concepts of assessing detection capability are adapted from other imaging or mass spectrometry (MS)-based technologies to improve upon the reliability of IMS quantification. Materials & methods: The mimetic tissue model is prepared by serially freezing spiked-tissue homogenates into a cylindrical mold to create a plug of tissue with a stepped concentration gradient of matrix-matched standards. Weighted least squares (WLS) linear regression is applied due to the heteroscedastisity (change in variance with intensity) of most MS data. Results & conclusions: Imaging poses several caveats for quantification which are unique compared with other MS-based methods. Aspects of the design, construction, application, and evaluation of the matrix-matched standard curve for the mimetic tissue model are discussed. In addition, the criticality of the ion distribution in the design of a purposeful liquid chromatography coupled to mass spectrometry (LC-MS) validation is reviewed.

Keywords:  LC–MS validation; detection capability; imaging MS; mimetic tissue model; quantification

Year:  2019        PMID: 31251106     DOI: 10.4155/bio-2019-0035

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  8 in total

1.  An optimized method for the detection and spatial distribution of aminoglycoside and vancomycin antibiotics in tissue sections by mass spectrometry imaging.

Authors:  Ning Wang; Véronique Dartois; Claire L Carter
Journal:  J Mass Spectrom       Date:  2021-03       Impact factor: 1.982

2.  Quantitative Imaging Analysis of the Spatial Relationship between Antiretrovirals, Reverse Transcriptase Simian-Human Immunodeficiency Virus RNA, and Fibrosis in the Spleens of Nonhuman Primates.

Authors:  Aaron S Devanathan; Nicole R White; Yury Desyaterik; Gabriela De la Cruz; Michael Nekorchuk; Margaret Terry; Kathleen Busman-Sahay; Lourdes Adamson; Paul Luciw; Yuri Fedoriw; Jacob D Estes; Elias P Rosen; Angela D M Kashuba
Journal:  Antimicrob Agents Chemother       Date:  2022-07-20       Impact factor: 5.938

Review 3.  MALDI-MSI Towards Multimodal Imaging: Challenges and Perspectives.

Authors:  Michael Tuck; Florent Grélard; Landry Blanc; Nicolas Desbenoit
Journal:  Front Chem       Date:  2022-05-09       Impact factor: 5.545

Review 4.  MALDI imaging mass spectrometry: an emerging tool in neurology.

Authors:  Laura K Schnackenberg; David A Thorn; Dustyn Barnette; E Ellen Jones
Journal:  Metab Brain Dis       Date:  2021-08-04       Impact factor: 3.584

5.  Quantitative mass spectrometry imaging of drugs and metabolites: a multiplatform comparison.

Authors:  Lieke Lamont; Darya Hadavi; Brent Viehmann; Bryn Flinders; Ron M A Heeren; Rob J Vreeken; Tiffany Porta Siegel
Journal:  Anal Bioanal Chem       Date:  2021-03-26       Impact factor: 4.142

6.  Spatial quantitation of antibiotics in bone tissue compartments by laser-capture microdissection coupled with UHPLC-tandem mass spectrometry.

Authors:  Firat Kaya; Matthew D Zimmerman; Rosleine Antilus-Sainte; Martin Gengenbacher; Claire L Carter; Véronique Dartois
Journal:  Anal Bioanal Chem       Date:  2022-08-10       Impact factor: 4.478

7.  Quantitative determination of niraparib and olaparib tumor distribution by mass spectrometry imaging.

Authors:  Lavinia Morosi; Cristina Matteo; Tommaso Ceruti; Silvia Giordano; Marianna Ponzo; Roberta Frapolli; Massimo Zucchetti; Enrico Davoli; Maurizio D'Incalci; Paolo Ubezio
Journal:  Int J Biol Sci       Date:  2020-02-21       Impact factor: 6.580

8.  The emergence of imaging mass spectrometry in drug discovery and development: Making a difference by driving decision making.

Authors:  Stephen Castellino; Nichole M Lareau; Mark Reid Groseclose
Journal:  J Mass Spectrom       Date:  2021-03-16       Impact factor: 1.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.